MC

Mita Chopra

Active Director Director DIN 00535249
DIN 00535249 First appointment Sep 1991 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 1991
Shareholding value Locked Premium profile

About Mita Chopra

Mita Chopra has 34 years in corporate governance. Holds Director role. Currently with 1 company, including Triumph Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00535249
Primary Designation Director
First Appointment 18 Sep 1991
Oldest Company Age 45 yrs

Current companies

Company Designation Appointment Founded Status
Director 18 Sep 1991 1980 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Triumph Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mita Chopra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mita Chopra

Mita Chopra has 34 years in corporate governance. Holds Director role. Currently with 1 company, including Triumph Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Mita Chopra is associated with 1 company as Director.

Mita Chopra has expertise in General Business.

Mita Chopra has 34 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available